About the Authors
- Jun-ichi Oyama
-
* E-mail: junoyama@cc.saga-u.ac.jp (JO); node@cc.saga-u.ac.jp (KN)
Affiliation Department of Cardiovascular Medicine, Saga University, Saga, Japan
- Toyoaki Murohara
-
Affiliation Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
- Masafumi Kitakaze
-
Affiliation Department of Clinical Medicine and Development, National Cerebral and Cardiovascular Center, Osaka, Japan
- Tomoko Ishizu
-
Affiliation Department of Clinical Laboratory Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
- Yasunori Sato
-
Affiliation Department of Global Clinical Research, Graduate School of Medicine, Chiba University, Chiba, Japan
- Kazuo Kitagawa
-
Affiliation Department of Neurology, Tokyo Women’s Medical University, Tokyo, Japan
- Haruo Kamiya
-
Affiliation Division of Cardiology, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Japan
- Masayoshi Ajioka
-
Affiliation Department of Cardiovascular Internal Medicine, Tosei General Hospital, Seto, Japan
- Masaharu Ishihara
-
Affiliation Division of Cardiovascular Medicine and Coronary Heart Disease, Hyogo College of Medicine, Nishinomiya, Japan
- Kazuoki Dai
-
Affiliation Department of Cardiology, Hiroshima City Hospital, Hiroshima, Japan
- Mamoru Nanasato
-
Affiliation Cardiovascular Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan
- Masataka Sata
-
Affiliation Department of Cardiovascular Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan
- Koji Maemura
-
Affiliation Department of Cardiovascular Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
- Hirofumi Tomiyama
-
Affiliation Department of Cardiology, Tokyo Medical University, Tokyo, Japan
- Yukihito Higashi
-
Affiliation Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
- Kohei Kaku
-
Affiliation Department of Internal Medicine, Kawasaki Medical School, Kurashiki, Japan
- Hirotsugu Yamada
-
Affiliation Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
- Munehide Matsuhisa
-
Affiliation Diabetes Therapeutics and Research Center, Tokushima University, Tokushima, Japan
- Kentaro Yamashita
-
Affiliation Department of Cardiology, Nagoya University Graduate School of Medicine and National Hospital Organization Nagoya Medical Center, Nagoya, Japan
- Yasuko K. Bando
-
Affiliation Department of Cardiology, Nagoya University Graduate School of Medicine and National Hospital Organization Nagoya Medical Center, Nagoya, Japan
- Naoki Kashihara
-
Affiliation Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan
- Shinichiro Ueda
-
Affiliation Department of Clinical Pharmacology and Therapeutics, University of the Ryukyus, Nishihara, Japan
- Teruo Inoue
-
Affiliation Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan
- Atsushi Tanaka
-
Affiliation Department of Cardiovascular Medicine, Saga University, Saga, Japan
- Koichi Node
-
* E-mail: junoyama@cc.saga-u.ac.jp (JO); node@cc.saga-u.ac.jp (KN)
Affiliation Department of Cardiovascular Medicine, Saga University, Saga, Japan
- PROLOGUE Study Investigators
-
¶A complete list of the PROLOGUE (Program of Vascular Evaluation under Glucose Control by DPP-4 Inhibitor) Study Investigators is provided in the Acknowledgments.
Competing Interests
JO belongs to the research program faculty (chair course) sponsored by Fukuda Denshi. YKB MI KKa NK MK KM TM MS SU HY received honoraria from pharmaceutical companies including MSD. MI MK KM received honoraria from pharmaceutical companies including Ono. KN received honoraria from pharmaceutical companies including Merck. YKB MI NK KM TM MS SU HY received research grants from pharmaceutical companies including MSD. MI MK MS HY received research grants from pharmaceutical companies including Ono. KKi MM YS HT received honoraria from pharmaceutical companies. KKa KKi MM KN YS received research grants from pharmaceutical companies. All other authors declare that they have no conflict of interest. A full list of competing interests is provided in S6 Text.
Author Contributions
Conceived and designed the experiments: MA YKB KD YH TIn MI TIs KKa HK NK KKi MK KM MM TM MN KN JO MS YS AT HT SU HY KY. Performed the experiments: MA YKB KD YH TIn MI TIs KKa HK NK MK KM MM TM MN KN JO MS HT SU HY KY. Analyzed the data: YS AT. Contributed reagents/materials/analysis tools: TIs YS. Wrote the first draft of the manuscript: MA YKB YH TIn TIs NK MK KM MM TM KN JO MS YS HT SU HY. Contributed to the writing of the manuscript: MA YKB KD YH TIn MI TIs KKa HK NK KKi MK KM MM TM MN KN JO MS YS AT HT SU HY KY. Enrolled patients: MA YB KD YH TIn TIs KKa HK MK KM MM TM MN KN JO HT HY KY. Agree with the manuscript’s results and conclusions: MA YKB KD YH TIn MI TIs KKa HK NK KKi MK KM MM TM MN KN JO MS YS AT HT SU HY KY. All authors are members of the PROLOGUE Study Investigators. All authors have read, and confirm that they meet, ICMJE criteria for authorship.